Intermolecular Interactions between a Membrane Protein and a Glycolipid Essential for Membrane Protein Integration. 2022

Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
Bioorganic Research Institute, Suntory Foundation for Life Sciences, 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan.

Inducing newly synthesized proteins to appropriate locations is an indispensable biological function in every organism. Integration of proteins into biomembranes in Escherichia coli is mediated by proteinaceous factors, such as Sec translocons and an insertase YidC. Additionally, a glycolipid named MPIase (membrane protein integrase), composed of a long sugar chain and pyrophospholipid, was proven essential for membrane protein integration. We reported that a synthesized minimal unit of MPIase possessing only one trisaccharide, mini-MPIase-3, involves an essential structure for the integration activity. Here, to elucidate integration mechanisms using MPIase, we analyzed intermolecular interactions of MPIase or its synthetic analogs with a model substrate, the Pf3 coat protein, using physicochemical methods. Surface plasmon resonance (SPR) analyses revealed the importance of a pyrophosphate for affinity to the Pf3 coat protein. Compared with mini-MPIase-3, natural MPIase showed faster association and dissociation due to its long sugar chain despite the slight difference in affinity. To focus on more detailed MPIase substructures, we performed docking simulations and saturation transfer difference-nuclear magnetic resonance. These experiments yielded that the 6-O-acetyl group on glucosamine and the phosphate of MPIase play important roles leading to interactions with the Pf3 coat protein. The high affinity of MPIase to the hydrophobic region and the basic amino acid residues of the protein was suggested by docking simulations and proven experimentally by SPR using protein mutants devoid of target regions. These results demonstrated the direct interactions of MPIase with a substrate protein and revealed detailed mechanisms of membrane protein integration.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006017 Glycolipids Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage) Glycolipid
D000073893 Sugars Short chain carbohydrate molecules that have hydroxyl groups attached to each carbon atom unit with the exception of one carbon that has a doubly-bond aldehyde or ketone oxygen. Cyclical sugar molecules are formed when the aldehyde or ketone groups respectively form a hemiacetal or hemiketal bond with one of the hydroxyl carbons. The three dimensional structure of the sugar molecule occurs in a vast array of biological and synthetic classes of specialized compounds including AMINO SUGARS; CARBASUGARS; DEOXY SUGARS; SUGAR ACIDS; SUGAR ALCOHOLS; and SUGAR PHOSPHATES. Sugar
D026901 Membrane Transport Proteins Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport (BIOLOGICAL TRANSPORT, ACTIVE), facilitated transport and ION CHANNELS. Biological Pump,Membrane Transport Protein,Membrane Transporter,Membrane Transporters,Metabolic Pump,Permease,Biological Pumps,Metabolic Pumps,Permeases,Pump, Biologic,Pump, Biological,Pump, Metabolic,Pumps, Biological,Pumps, Metabolic,Biologic Pump,Protein, Membrane Transport,Transport Protein, Membrane,Transport Proteins, Membrane,Transporter, Membrane,Transporters, Membrane
D029968 Escherichia coli Proteins Proteins obtained from ESCHERICHIA COLI. E coli Proteins

Related Publications

Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
January 2022, Advances in carbohydrate chemistry and biochemistry,
Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
February 2019, Scientific reports,
Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
January 2012, Nature communications,
Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
December 2006, Cellular immunology,
Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
April 2013, Carbohydrate polymers,
Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
October 1995, Biochemistry,
Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
September 1988, Journal of biochemistry,
Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
September 2020, ACS omega,
Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
July 2012, Analytical and bioanalytical chemistry,
Shoko Mori, and Kaoru Nomura, and Kohki Fujikawa, and Tsukiho Osawa, and Masafumi Shionyu, and Takao Yoda, and Tsuyoshi Shirai, and Shugo Tsuda, and Kumiko Yoshizawa-Kumagaye, and Shun Masuda, and Hideki Nishio, and Taku Yoshiya, and Sonomi Suzuki, and Maki Muramoto, and Ken-Ichi Nishiyama, and Keiko Shimamoto
March 2019, Biochemical and biophysical research communications,
Copied contents to your clipboard!